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Response differences of HepG2 
and Primary Mouse Hepatocytes 
to morphological changes 
in electrospun PCL scaffolds
Thomas S. R. Bate1, Victoria L. Gadd2, Stuart J. Forbes2 & Anthony Callanan1*
Liver disease cases are rapidly expanding across the globe and the only effective cure for end-stage 
disease is a transplant. Transplant procedures are costly and current supply of donor livers does not 
satisfy demand. Potential drug treatments and regenerative therapies that are being developed to 
tackle these pressing issues require effective in-vitro culture platforms. Electrospun scaffolds provide 
bio-mimetic structures upon which cells are cultured to regulate function in-vitro. This study aims to 
shed light on the effects of electrospun PCL morphology on the culture of an immortalised hepatic 
cell line and mouse primary hepatocytes. Each cell type was cultured on large 4–5 µm fibres and 
small 1–2 µm fibres with random, aligned and highly porous cryogenically spun configurations. Cell 
attachment, proliferation, morphology and functional protein and gene expression was analysed. 
Results show that fibre morphology has a measurable influence on cellular morphology and function, 
with the alteration of key functional markers such as CYP1A2 expression.
Recent decades have seen alarming rises in the rates of chronic liver diseases and hepatocellular  carcinoma1–3. 
The breadth of liver related pathologies is large and the associated epidemiology is highly  complex4,5. Liver 
transplantation is currently the only feasible cure to end-stage liver disease, but it is costly and donor supply 
satisfies only 10% of  demand5. Several strategies are being employed to try to tackle these issues and the search 
for novel and effective treatments is  underway6. Finding therapeutic targets for drug based treatment of pre-
cirrhotic liver disease is of high importance to effect an economical solution to this  problem6. Other research 
is focused on regenerative therapies through the use of stem cells or macrophages and extra-cellular matrix 
(ECM) scaffolding technologies to remove or reverse the currently irreversible results of liver  cirrhosis7–11. These 
methods imply the utilisation of in-vitro methods which are in need of re-development and re-engineering to 
match in-vivo biological complexity and deliver effective platforms for expansion of regenerative cells and in-
vitro drug testing  models11–13.
In-vitro culture of hepatocytes has developed from standard culture methods to collagen sandwich cul-
tures, organoid cultures and microfluidic organ-on-a chip  cultures14,15. While each of these methods carries 
their limitations, the scope for further options has been expanded by research into novel scaffold technologies. 
Scaffolds take the form of bio-compatible porous hydrogels or polymer microstructures, and supply cells with 
a bio-mimetic extracellular structure upon which to  attach16. Amongst the various available methods, recent 
research has identified electrospun polymer scaffolds as a potential avenue for the production of effective in-
vitro liver tissue  models17–21.
Electrospinning is a polymer fabrication technique that yields fibres from the nano to micro scale that can 
mimic the structure of the native  ECM22. Electrospun bio-compatible polymers have been used in the production 
of 3D cell cultures for various tissues and for various  applications23–28. It is a reliable and tailorable technique 
giving a high degree of freedom in altering the dimensional aspects of the fibrous matrix. Fibre size, morphol-
ogy and connectivity can be easily manipulated, which has contributed to the method’s popularity among tissue 
engineering  researchers22,29–31. There are plenty of examples in literature of these attributes being exploited, such 
as to produce artificial conduits for nerve grafts and in finding optimal fibre characteristics for in-vitro kidney 
tissue  models25,32. The ability to alter the fibre characteristics provides the opportunity to investigate the effects 
of fibre characteristics on cellular function.
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The mechanical properties of cell culture substrates can have a direct influence on cellular behaviour and 
function through a process termed  mechanotransduction33. It is known that this influence affects the morphol-
ogy of adherent cells, the cytokinesis process, cellular migration and  differentiation34. These effects have been 
demonstrated through studies focused on stem cells, and are known to translate over to fully differentiated 
somatic cell types. Microenvironment stiffness has been utilised as a tool for directing differentiation of hepatic 
stem cells/progenitors within in-vitro hydrogel  models35,36. It has also been shown that substrate stiffness can 
be used to regulate the function of primary hepatocytes from rats and  humans37,38. Thus, consideration of the 
mechanical properties of 3D scaffold technologies and how this regulates cell function is essential to the design 
of in-vitro systems.
Herein, we report the in-vitro effects of electrospun PCL fibre morphology on the hepg2 cell line and isolated 
primary mouse hepatocytes (MPH). We have constructed six groups of scaffolds with different morphologies and 
fibre sizes by altering electrospinning parameters. The morphological categories include random fibres, aligned 
fibres and higher porosity cryogenic fibres. Each morphological category has been produced with a small fibre 
size (1–2 µm) and a large fibre size (4–5 µm). This provides an array of different mechanical microenvironments 
which allows us to understand the extent to which electrospun fibre mechanics influences hepatic cell cultures 
and apply this information to the design of in-vitro hepatocyte culture systems.
Results
Scaffold properties. The scaffold fabrication methods used in this study produced three distinct PCL scaf-
fold morphologies, as shown in Fig. 1A, with large (4–5 µm) and small (1–2 µm) fibres. Control of fibre size was 
implemented through alteration of polymer concentration, solvent choice and electrospinning parameters. The 
morphology of the deposited fibres was controlled by varying mandrel speed and temperature. Figure 1B shows 
the effect that fibre size and morphology have on the mechanical properties of the resulting scaffolds. Morpho-
logical characteristics have a stronger effect on the mechanical properties, however it is clear that fibre size also 
has influence.
Cell morphology. The morphological effects of each scaffold on hepg2s and MPHs is displayed in Fig. 2. 
Cells adopt a more rounded morphology on the random scaffolds and are significantly elongated on the aligned 
fibres. The morphology of cells that have attached to fibres in the cryogenic scaffolds adheres to the morphol-
ogy of the fibre. However, these cryogenic scaffolds also show indications of cellular infiltration and trapping of 
unattached cells within the large pores.
Cell viability. Cell titre blue results in Fig. 3 showed hepg2 cells exhibited increased cell viability over the 
14 day culture period. Due to the highly proliferative nature of the hepg2s this is likely due to increases in the cell 
number upon the scaffold. Larger fibres tended to increase level of viability measured, however no statistically 
significant differences were observed between the groups.
In contrast to the hepg2s the MPHs exhibited a steady decline in cell viability over a 3 day culture period. This 
is largely due to cell death within the culture of MPHs, which is common amongst primary hepatocyte  cultures39. 
Again, larger fibres tended to increase the viability levels with the exception of the SM-RA group. Statistically 
significant differences were observed between the SM-CR scaffold and each of the LG-RA and LG-AL scaffold 
groups at 48 h (p < 0.05). Interestingly, significantly increased fluorescence was observed on the LG-CR scaffold 
in comparison to the SM-CR scaffold (p < 0.05), which suggests higher attachment on the larger fibres.
DNA. dsDNA levels have been quantified in order to understand cell attachment and proliferation behaviour. 
This can also confirm if cell viability changes are characterised by changes in cell number or cell metabolism. 
Measured dsDNA levels in the hepg2 cultures (Fig. 4A) showed consistent increases across the 14 day culture 
period. Cryogenic scaffold groups showed higher rates of increase with statistically significant increases from 
24-h to 14-days (p < 0.001).
The capacity for MPHs attachment was similar between scaffolds as evidenced by consistent levels of dsDNA 
at 24 h (Fig. 4B). In contrast to HepG2, MPHs exhibited consistent decreases in the dsDNA levels over the 3 day 
culture period, displayed in (Fig. 4B). The LG-CR scaffolds held significantly higher levels of dsDNA at 24 and 
48 h compared with each of the SM scaffold groups (p < 0.05–0.001) and the LG-RA group (p < 0.05).
Albumin. Albumin secretion displayed in Fig.  5A, measured by bromocresol green assay, showed hepg2 
secreted between 0.2 and 0.3 g/dL over a 24 h period at all timepoints. At 14 days hepg2s on the LG-CR scaffold 
showed significantly increased secretion over 24  h compared with all other groups except LG-AL (p < 0.05–
0.001).
Figure 5B shows that MPHs exhibited 0.02–0.05 g/dL albumin secretion over a 24 h period for all timepoints. 
No significant differences in albumin secretion were observed between groups.
Gene expression. Gene expression analysis for hepg2 cells shown in Fig.  6 confirms the expression of 
COL1A1, FN1, ALB, CYP3A4 and CYP1A2. Relative expression of genes between groups showed no significant 
differences. CYP3A4 and ALB exhibited increases in expression over the 14 day culture period, whilst decreases 
were observed in COL1A1, FN1 and CYP1A2.
MPHs were confirmed to show expression of COL1A1, COL3A1, AFP1, HNF4a, CYP1A2 and CYP2E1, seen 
in Fig. 7. COL1A1, COL3A1 and AFP1 were seen to increase over the 3 day culture period, and HNF4a, CYP1A2 
and CYP2E1 were seen to decrease. Significant increases in the expression of CYP1A2 between the cryogenic 
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groups and all of the other groups were observed after 48 h of culture time (p < 0.05–0.001, these are provided 
in the Supplementary Information).
Discussion
The mechanical properties of the scaffolds are a result of the combination of fibre bending stiffness and the mode 
of fibre connectivity within the fibrous  matrix40. Depending on these two parameters, under load each scaffold 
will exhibit either bending dominant or stretching dominant deformation which has a large impact on the 
macro-mechanical behaviour of the fibrous  material41. Apart from mechanical considerations, the morphologi-
cal changes between each scaffold type can be observed at the cell scale. Therefore, it was reasonable to assume 
that these structural characteristics would have an influence on the morphology of attached cells. The scaffolds 
produced thus displayed properties that would make them a useful platform on which to test the mechanical 
and morphological influence of electrospun fibres on hepatocyte cultures. This is important in order to develop 
in-vitro platforms that can induce mechanically and morphologically relevant cultures, and produce effective 
Figure 1.  (A) SEM images of scaffold fibres for each group. (B) Fibre diameter measurements from Diameter 
J plugin, Tensile mechanical stiffness for each scaffold group (N = 5 presented as mean ± SD), Contact angle 
measurements for each scaffold group (0 indicates droplet completely absorbed) before and after plasma 
treatment and porosity measurements.
4
Vol:.(1234567890)
Scientific Reports |         (2021) 11:3059  | https://doi.org/10.1038/s41598-021-81761-z
www.nature.com/scientificreports/
culture environments for cell therapy and drug testing workflows. The analysis was conducted such that standard 
tissue culture plastic (TCP) controls were omitted in order the focus the analysis on the morphological factors, 
previous reports in literature have explored comparisons between 3D scaffold cultures and 2D TCP  culture21,42,43.
Cellular attachment of hepg2 was observed on all scaffolds and each scaffold is shown to have facilitated an 
equal measure of attachment, as shown by levels of DNA at 24 h in Fig. 4. The hepg2 were then allowed to pro-
liferate over 14 days to understand if the electrospun scaffolds exert influence across the short term and the long 
term. No significant differences were exhibited between the scaffold groups throughout the entire culture period. 
Although trends in the DNA and viability results indicate that larger pores in the scaffolds promote higher rates 
of proliferative activity. It is widely understood that scaffold porosity and pore size can act on the migration and 
proliferation behaviours of cells within  scaffolds44,45.
MPHs were seen also to attach PCL fibres successfully and were observed upon the scaffolds for three days. 
DNA results shown in Fig. 4B indicate significantly higher levels of cellular attachment in the LG-CR group, this 
is also reflected in the overall improved viability on large scaffolds seen in Fig. 3B. It is thought this is likely due to 
more cells becoming trapped in the larger pores of the scaffold. Over the course of three days the MPHs were seen 
Figure 2.  DAPI and Phalloidin fluorescence images showing cellular morphology upon scaffolds at 48 h (A) 
Hepg2, (B) MPHs. Images taken with ×40 magnification objective.
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to decline in population on the scaffolds, it was expected that this was to happen with MPHs, which are notori-
ously non-proliferative in-vitro and rapidly progress to  apoptosis39. The SM-CR group showed reduced levels 
of viability compared to the LG-RA and LG-AL groups at 48 h. As this is not reflected in the levels of DNA it is 
possible that the smaller fibres and reduced connectivity of the SM-CR scaffold has an inhibitory effect on meta-
bolic activity, however more rigorous analysis of metabolic activity would be necessary to confirm such effects.
Albumin secretion was confirmed for both cell types upon the electrospun PCL scaffolds, seen in Fig. 5. Albu-
min is a physiologically important molecule secreted by hepatocytes which regulates colloidal osmotic pressure 
and the transportation of molecules throughout the body, amongst other important physiological  processes46,47. 
The production of albumin in-vitro is thus essential for an effective model of hepatocyte function. No major 
differences in albumin secretion were observed between groups, apart from the hepg2 on the LG-CR scaffold at 
14 days. This is not supported by evidence of significantly increased cell population, therefore scaffold porosity 
may drive albumin secretion through more extensive 3D cell agglomeration, which has been shown to augment 
albumin production in hepatic cell  lines48.
Gene expression was analysed for Albumin, CYP1A2 and CYP3A4 genes to show expression of hepatic 
functional markers for hepg2. Expression of COL1A1 and FN1 were also analysed to observe the effects on ECM 
production. Scaffold morphology was not highly influential on the expression of genes analysed, as confirmed in 
Fig. 6 Hepg2 cells showed fairly consistent expression profiles for all genes between scaffold groups. There were 
trends noted in the expression of COL1A1 where expression after 14 days was seen to be reduced with fibre size 
and particularly on the LG-CR group.
Figure 3.  Cell titre blue fluorescence results for (A) hepg2 over 14 days and (B) MPHs over 3 days. N = 5, Error 
bars = SD and *p < 0.05, **p < 0.01 and ***p < 0.001.
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In accordance with hepg2, MPHs also exhibited a largely unaffected expression of functional markers (AFP, 
HNF4a and CYP2E1) and ECM genes (COL1A1 and COL3A1) across the morphological categories. This is with 
the exception of CYP1A2, in which statistically a significant increase in expression was observed on the cryogenic 
scaffolds SM-CR and LG-CR after 48 h of culture, which can be seen in Fig. 7. CYP1A2 is a cytochrome P450 
protein primarily associated with the metabolism of caffeine, drugs and other  xenobiotics49–51. The cryogenic 
scaffolds share higher porosity in comparison to the other morphological categories shown by the porosity data 
in Fig. 1. A higher porosity allows for deeper scaffold infiltration and facilitates a higher degree of 3-D agglom-
eration of the cells within the scaffold, constructing a more organoidal arrangement. CYP1A2 expression and 
activity has been found to be increased in 3D culture conditions in comparison to 2D  methods43,52. Accordingly, 
it is proposed that the 3D structural arrangements driven by the higher porosity in cryogenic electrospun scaf-
folds may influence CYP1A2 expression. This supports evidence in literature that suggests scaffold pore size 
and geometry can have an impact on several aspects of hepatocyte  function53,54. It should be noted that the gene 
expression panels in Figs. 6 and 7 are not for the same genes due to the known differences in gene expression 
profiles between hepG2 and primary  hepatocytes55–58. A comparison between the two cell types would not fall 
within the scope of this study.
Electrospun PCL scaffold morphology has a direct impact on the morphology of hepg2 and MPH cell cul-
tures which, in turn, show to produce significant biological responses. This is confirmed by results showing 
altered scaffold-cell attachment, proliferation rates and changes to the expression of major hepatocyte functional 
markers, such as CYP1A2. The results imply that fibre size and porosity both have measurable influence on the 
cultures. In particular, the higher occurrences of 3-dimensional cell–cell interactions in scaffolds with higher 
Figure 4.  Picogreen dsDNA measurements for (A) hepg2 over 14 days and (B) MPHs over 3 days. N = 5, Error 
bars = SD and *p < 0.05, **p < 0.01 and ***p < 0.001.
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porosity show to consistently affect cell function in a significant manner. This study opens questions about how 
electrospun scaffold morphology should be utilised to harness bio-realistic in-vitro cultures of hepatocellular-
carcinoma and primary mouse hepatocytes.
Method
Electrospinning. Electrospun PCL scaffolds of differing morphology were produced using a previously 
described  methods23,59. The scaffolds were fabricated by solution electrospinning on an IME Technologies elec-
trospinning apparatus with a rotating mandrel attachment. To produce the six different architectures a vari-
ety of electrospinning parameters were used shown in Fig. 8. PCL was dissolved in different solvent systems 
Chloroform:Methanol 5:1, Chloroform:Methanol 3:1 and Hexafluoroisopropanol (HFIP) to achieve different 
fibre sizes, an approach demonstrated in  literature23,54,60. For each scaffold, 4 mL of solution was used to spin a 
100 mm wide sheet of electrospun material from which 10 mm discs were punched out. These discs were stored 
at room temperature awaiting plasma treatment and seeding.
Scanning electron microscopy. Samples were sputter coated with gold in an EmScope 5000 sputter 
coater for 30 s before imaging. Post sputter coating, SEM images of the samples were taken at 15 kV accelerating 
voltage using a Hitachi TM4000 Plus benchtop scanning electron microscope.
Fibre diameter. Fibre diameter was measured on ImageJ software using the DiameterJ  plugin61. SEM 
images were segmented and analysed to find the average fibre diameter for each scaffold.
Figure 5.  Bromocresol green 24 h albumin secretion measurements for (A) hepg2 over 14 days (N = 5) and (B) 
MPHs over 3 days (N = 3). Error bars = SD and *p < 0.05, **p < 0.01 and ***p < 0.001.
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Porosity measurement. 50 × 10  mm (N = 3) sections of scaffold material were cut using a scalpel. The 
samples were measured for thickness using a DMK 41AU02 (ImagingSource) camera and weighed. With knowl-
edge of the scaffold weight and dimensions and the density of the PCL (Sigma) the porosity was calculated using 
the following equation:
where p is porosity,  VPCL the volume of PCL calculated from the weight and density (1.145 g/mL) and  VScaffold 
the volume of the scaffold.
Mechanical testing. Electrospun material was subject to tensile testing using the Instron 3367 universal 
testing system. Briefly, 10 × 50 mm samples were cut using a scalpel and mounted 10 mm at each end in pneu-
matic clamps giving a gauge length of 30 mm. The samples (N = 5) were then elongated parallel to the mandrel 
rotation direction at 50% strain per minute (15 mm/m), strain was measured as longitudinal elongation as a 
proportion of gauge length. For the aligned fibres the tensile test was conducted both parallel and perpendicular 








Figure 6.  RT-qPCR gene expression results showing fold change of COL1A1, FN1, CYP1A2, CYP3A4 and 
ALB for hepg2 over 14 days. Results normalised to hepg2 on SM.RA at 24 h. N ≤ 5, Error bars = SD and *p < 0.05, 
**p < 0.01 and ***p < 0.001.
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using a 50 N rated Instron 2530-50N load cell. Sample thickness was measured using a DMK 41AU02 (Imaging-
Source) camera. The camera was mounted perpendicular to the scaffold and pictures taken with a scale. Thick-
ness measurements were then taken digitally using ImageJ software. After data collection Youngs’ Moduli for 
each scaffold were calculated on MATLAB for different strain ranges by taking a regression of the stress–strain 
data between 0–5%, 5–10%, 10–15% and 15–20% strain.
Contact angle measurement. 5 µL of  dH2O were pipetted on to the surface of each scaffold and images 
were taken at 5 Hz using a DMK 41AU02 (ImagingSource) camera. Contact angles for both non-plasma treated 
scaffolds and plasma treated scaffolds were subsequently measured using LBADSA plugin with  ImageJ62.
Plasma treatment. To improve the hydrophilicity of the PCL surface, the scaffolds were oxygen plasma 
treated (Harrick Plasma) prior to seeding. Briefly, the scaffolds were sterilised in 70% Ethanol for 20 min before 
being freeze dried for 24 h. The sterile scaffolds were then exposed to oxygen plasma at 500 mTorr at medium RF 
Figure 7.  RT-qPCR gene expression results showing fold change of COL1A1, COL3A1, AFP1, HNF4a, 
CYP1A2 and CYP2E1 for MPHs over 3 days. Results normalised to MPHs on SM.RA at 24 h. N ≤ 5, Error 
bars = SD and *p < 0.05, **p < 0.01 and ***p < 0.001.
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power (20 W) for 30 s. Once plasma treated the scaffolds were immediately placed into 1% Anti-Anti solution in 
PBS, preventing hydrophobic recovery.
Immortalised cell line culture: HepG2. 1.0 × 106 hepG2 cells (Sigma) were raised at P6 in 3 T75 tissue 
culture flasks until 80% confluency in complete media, containing EMEM (Gibco) supplemented with 10% 
Fetal Bovine Serum (GE healthcare), 5% Non-essential amino acids (Gibco), 5% l-Glutamine (Gibco) and 
5 mL 10,000 U/mL Penicillin–Streptomycin (Gibco). Cells were then trypsinised using standard methods and 
counted with a haemocytometer. The cells were re-suspended in complete media and seeded onto the scaffolds 
at a concentration of 1 × 105 cells/scaffold. The seeded cells were incubated for 2.5 h at 37 °C and 5%  CO2 to allow 
for cell attachment. 300 µL complete media was subsequently added and the cells incubated at 37 °C and 5%  CO2 
for 14 days, changing media every 2–3 days.
Figure 8.  (A) Diagram depicting the electrospinning process for random, aligned and cryogenic fibres (top 
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Primary Mouse Hepatocyte isolation and culture. Primary Mouse Hepatocytes were isolated follow-
ing the standard two-step collagenase perfusion  technique63. Briefly, mice received a terminal dose of anaesthetic 
and underwent laparotomy. The portal vein was cannulated and then perfused with 50  mL Liver Perfusion 
Medium (Gibco) followed by 50 mL Liver Digest Medium (Gibco) pre-warmed to 37 °C. The liver was removed 
and then hepatocytes were mechanically disassociated and released from the Glisson capsule, filtered through 70 
μM filter and purified with a density gradient centrifugation. The cells were seeded at a concentration of 5 × 104 
cells/scaffold.
All experiments with animals were approved by the University of Edinburgh Animal Welfare and Ethical 
Review Body and the UK Home Office. All experiments with animals took place at the Centre for Regenerative 
Medicine, Edinburgh and were performed according to procedural guidelines and severity protocols from the 
UK Home Office Animals Scientific Procedures Act.
Cell viability. Cell viability was assessed using the Cell Titre Blue assay (Promega). The assay was conducted 
according to the manufacturer’s instructions. Briefly, cell laden scaffolds were incubated at 37 °C and 5%  CO2 in 
a 5:1 ratio of complete media and Cell Titre Blue reagent for 4 h. 100 µL of the resulting media solution was then 
measured for fluorescence at ex. 525 nm em. 580–640 nm on a Modulus II Microplate reader.
DNA quantitation. The amount of dsDNA present on each scaffold was measured using the Quant-IT 
Picogreen assay (Thermo-Fischer). Scaffolds were washed three times in PBS before being lyophilised. The 
lyophilised scaffolds were then placed in a Papain digest solution consisting of 2.5 U/mL Papain, 5 mM Cysteine 
HCl, 100 mM EDTA and 100 mM Sodium Acetate. Scaffolds were incubated at 65 °C in 1 mL of Papain digest 
solution for 24 h. Samples were then combined with Picogreen reagent as per manufacturer’s instructions. Sam-
ple fluorescence was read at ex 490 nm em 510–570 nm on a Modulus II Microplate reader.
Albumin quantitation. Albumin secretion over 24 h was quantified using the Bromocresol Green (BCG) 
reagent (Sigma) Media samples were removed from the scaffolds and stored at − 80 °C before measurement. 
Samples were spun down at 200g for 1 min and 5 µL added to the BCG reagent. Absorbance was measured at 
620 nm and normalised to a standard curve.
Cell imaging. Samples were washed 3 times in PBS before fixation in 10% formalin (Sigma) for 15 min, 
after fixation scaffolds were washed 3 times in PBS and stored at 4  °C before staining. Samples were stained 
with 300 nM 4′,6-diamidino-2-phenylindole (DAPI, Thermo-Fischer) in PBS and Phalloidin 514 nm conjugate 
(Sigma) in 1% BSA PBS solution for nucleic and f-actin visualisation respectively. Briefly, samples were washed 
3 times in PBS, exposed to DAPI solution for 10 min, washed 3 times in PBS, exposed to Phalloidin solution 
for 30 min and finally washed 3 times in PBS. Samples were imaged on a Zeiss AxxioImager epifluorescence 
microscope with 40× objective.
Gene expression. Samples were placed directly into 1 mL Tri-reagent and 200 µL of chloroform added, 
samples were spun down at 10,000g for 15 min and the mRNA containing supernatant was removed and placed 
into 400 µL of 70% ethanol. The ethanol and supernatant mRNA mixture was subsequently purified using Qia-
gen RNEasy Spin columns following the manufacturer’s instructions. After purification, 100 ng of mRNA was 
translated to cDNA using the Improm II Reverse Transcription kit (Promega) as per the manufacturer’s instruc-
tions. qPCR was then carried out with SYBR Green (Qiagen) using a Lightcycler 480 (Roche). Primers for hepG2 
were designed in a previous study and sequences are detailed in Supplementary Information. For the MPHs 
primers are listed in the Supplementary Information. Controls for gene expression analysis were the respective 
cells cultured on tissue culture plastic over 24 h. Results are expressed as fold-change values derived through the 
 2−∆∆Ct method.
Statistical analysis. All numerical data were subjected to one-way ANOVA and Tukey’s HSD post hoc 
testing. Statistical differences are displayed as: *p < 0.05, **p < 0.01 and ***p < 0.001.
Received: 18 May 2020; Accepted: 2 December 2020
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